By Dr Gary Kilov

Patient preference should be a major factor in driving the choice of glucose-lowering medications to treat type 2 diabetes.

For some people, the route of administration is key to compliance, especially for those with a fear of injections or conversely, a tendency to be non-adherent to daily oral medication.

Others worry about potential adverse effects or see inflexible treatment regimens as deal-breakers.